Heart failure in paediatric Crohn’s disease patient – extraintestinal manifestation, concomitant disease or iatrogenic effect?
Inflammatory bowel disease encompasses Crohn’s disease and ulcerative colitis, gastrointestinal conditions associated with increased risk of cardiovascular issues compared to those without that. These cardiovascular problems may include pericarditis, myocarditis, thromboembolism, arrhythmias, endoca...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Promenade Kft
2024-12-01
|
| Series: | Cardiologia Hungarica |
| Subjects: | |
| Online Access: | https://cardiologia.hungarica.eu/archive/2024-issues/2024-6-contents/heart-failure-in-paediatric-crohns-disease-patient-extraintestinal-manifestation-concomitant-disease-or-iatrogenic-effect?article=open |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1841557280113295360 |
|---|---|
| author | Snehil Swaraj Erzsébet Szakos László Ablonczy Csaba Vilmányi Ádám Goschler Áron Cseh |
| author_facet | Snehil Swaraj Erzsébet Szakos László Ablonczy Csaba Vilmányi Ádám Goschler Áron Cseh |
| author_sort | Snehil Swaraj |
| collection | DOAJ |
| description | Inflammatory bowel disease encompasses Crohn’s disease and ulcerative colitis, gastrointestinal conditions associated with increased risk of cardiovascular issues compared to those without that. These cardiovascular problems may include pericarditis, myocarditis, thromboembolism, arrhythmias, endocarditis, heart failure, Takayasu arteritis, valvulopathies, and atrioventricular block. However, limited literature exists on this topic in paediatric patients. The primary treatment for Crohn’s disease, the anti-tumor necrosis factor agent infliximab, has been linked to rare but serious cardiovascular complications. Here, we present a case study of a 7-year-old boy with Crohn’s disease whose cardiopulmonary function deteriorated after receiving infliximab therapy. |
| format | Article |
| id | doaj-art-22af8c13603d4f8ab7e78d47056c6299 |
| institution | Kabale University |
| issn | 0133-5596 1588-0230 |
| language | English |
| publishDate | 2024-12-01 |
| publisher | Promenade Kft |
| record_format | Article |
| series | Cardiologia Hungarica |
| spelling | doaj-art-22af8c13603d4f8ab7e78d47056c62992025-01-06T13:58:33ZengPromenade KftCardiologia Hungarica0133-55961588-02302024-12-01546454456Heart failure in paediatric Crohn’s disease patient – extraintestinal manifestation, concomitant disease or iatrogenic effect?Snehil Swaraj0Erzsébet Szakos1László Ablonczy2Csaba Vilmányi3Ádám Goschler4Áron Cseh5Semmelweis University, Paediatric Centre, BudapestB.-A.-Z. County Central University Hospital, Velkey László Paediatric Health Centre, Miskolc, University of Miskolc, MiskolcGottsegen National Cardiovascular Centre, Children's Heart Centre, BudapestGottsegen National Cardiovascular Centre, Children's Heart Centre, BudapestSemmelweis University, Paediatric Centre, BudapestSemmelweis University, Paediatric Centre, BudapestInflammatory bowel disease encompasses Crohn’s disease and ulcerative colitis, gastrointestinal conditions associated with increased risk of cardiovascular issues compared to those without that. These cardiovascular problems may include pericarditis, myocarditis, thromboembolism, arrhythmias, endocarditis, heart failure, Takayasu arteritis, valvulopathies, and atrioventricular block. However, limited literature exists on this topic in paediatric patients. The primary treatment for Crohn’s disease, the anti-tumor necrosis factor agent infliximab, has been linked to rare but serious cardiovascular complications. Here, we present a case study of a 7-year-old boy with Crohn’s disease whose cardiopulmonary function deteriorated after receiving infliximab therapy.https://cardiologia.hungarica.eu/archive/2024-issues/2024-6-contents/heart-failure-in-paediatric-crohns-disease-patient-extraintestinal-manifestation-concomitant-disease-or-iatrogenic-effect?article=openinflammatory diseasecrohn’s diseaseinfliximabdilated cardiomyopathyheart failureprobnp |
| spellingShingle | Snehil Swaraj Erzsébet Szakos László Ablonczy Csaba Vilmányi Ádám Goschler Áron Cseh Heart failure in paediatric Crohn’s disease patient – extraintestinal manifestation, concomitant disease or iatrogenic effect? Cardiologia Hungarica inflammatory disease crohn’s disease infliximab dilated cardiomyopathy heart failure probnp |
| title | Heart failure in paediatric Crohn’s disease patient – extraintestinal manifestation, concomitant disease or iatrogenic effect? |
| title_full | Heart failure in paediatric Crohn’s disease patient – extraintestinal manifestation, concomitant disease or iatrogenic effect? |
| title_fullStr | Heart failure in paediatric Crohn’s disease patient – extraintestinal manifestation, concomitant disease or iatrogenic effect? |
| title_full_unstemmed | Heart failure in paediatric Crohn’s disease patient – extraintestinal manifestation, concomitant disease or iatrogenic effect? |
| title_short | Heart failure in paediatric Crohn’s disease patient – extraintestinal manifestation, concomitant disease or iatrogenic effect? |
| title_sort | heart failure in paediatric crohn s disease patient extraintestinal manifestation concomitant disease or iatrogenic effect |
| topic | inflammatory disease crohn’s disease infliximab dilated cardiomyopathy heart failure probnp |
| url | https://cardiologia.hungarica.eu/archive/2024-issues/2024-6-contents/heart-failure-in-paediatric-crohns-disease-patient-extraintestinal-manifestation-concomitant-disease-or-iatrogenic-effect?article=open |
| work_keys_str_mv | AT snehilswaraj heartfailureinpaediatriccrohnsdiseasepatientextraintestinalmanifestationconcomitantdiseaseoriatrogeniceffect AT erzsebetszakos heartfailureinpaediatriccrohnsdiseasepatientextraintestinalmanifestationconcomitantdiseaseoriatrogeniceffect AT laszloablonczy heartfailureinpaediatriccrohnsdiseasepatientextraintestinalmanifestationconcomitantdiseaseoriatrogeniceffect AT csabavilmanyi heartfailureinpaediatriccrohnsdiseasepatientextraintestinalmanifestationconcomitantdiseaseoriatrogeniceffect AT adamgoschler heartfailureinpaediatriccrohnsdiseasepatientextraintestinalmanifestationconcomitantdiseaseoriatrogeniceffect AT aroncseh heartfailureinpaediatriccrohnsdiseasepatientextraintestinalmanifestationconcomitantdiseaseoriatrogeniceffect |